ORTHOWORLD estimates place overall market growth at 5% over 3Q10, as shown in Exhibit 1, which displays orthopaedic sales growth by product segment. Performance highlights follow, and relate to 3Q unless otherwise noted.
Exhibit 1: Orthopaedic Sales Increases1 by Product Segment: 3Q11 vs. 3Q10
Notes to Exhibit 1
1 Orthopaedic products only; constant currency, pro forma growth
2 Includes biologics
3 For the quarter ended 8/31/11; Spine includes Bone Stim and Biologics; Bone Stim reflects all Bone Healing sales.
4 For the quarter ended 10/28/11
6 For the quarter ended 9/30/11
7 Extremities: extremities + fixation combined; Endoscopy: endoscopic + communications, most of which is orthopaedic; Spine: neuro + spine. Total growth excludes Patient Handling.
8 ORTHOWORLD estimates
9 Excludes "Other" (Aerospace)